We provide you with 20 years of free, institutional-grade data for VANI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VANI. Explore the full financial landscape of VANI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Second Sight Medical Products Inc(NASDAQ:VANI) 
Vivani Medical, Inc. develops and commercializes drug and device implants to treat patients with chronic diseases with unmet medical need. Its lead product candidate is NPM-119, a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The company is based in Sylmar, Califor...
Share this website to your friends
The information provided in this report about VANI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.